OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs... Show more
a manufacturer of pharmaceutical products
Industry MedicalSpecialties
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DREGX | 58.12 | 0.78 | +1.36% |
| Driehaus Emerging Markets Growth Inv | |||
| ANTGX | 11.82 | 0.14 | +1.20% |
| American Century Non-US Intrs Val G | |||
| RNPAX | 69.31 | 0.66 | +0.96% |
| American Funds New Perspective R-1 | |||
| TGVYX | 58.30 | 0.26 | +0.45% |
| Touchstone Dynamic Large Cap Growth Y | |||
| MUSBX | 40.97 | 0.18 | +0.44% |
| MFS Blended Research Core Equity B | |||
A.I.dvisor indicates that over the last year, OPK has been loosely correlated with ICUI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then ICUI could also see price increases.
| Ticker / NAME | Correlation To OPK | 1D Price Change % | ||
|---|---|---|---|---|
| OPK | 100% | +1.37% | ||
| ICUI - OPK | 41% Loosely correlated | +0.17% | ||
| CLPT - OPK | 39% Loosely correlated | +1.32% | ||
| A - OPK | 37% Loosely correlated | +1.73% | ||
| CRL - OPK | 37% Loosely correlated | +1.28% | ||
| UTMD - OPK | 36% Loosely correlated | +0.18% | ||
More | ||||
The 10-day RSI Oscillator for OPK moved out of overbought territory on July 29, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
OPK broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for OPK entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on August 12, 2026. You may want to consider a long position or call options on OPK as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for OPK just turned positive on July 28, 2026. Looking at past instances where OPK's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .
OPK moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for OPK crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where OPK advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OPK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.933) is normal, around the industry mean (58.245). P/E Ratio (0.000) is within average values for comparable stocks, (155.381). OPK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.736). OPK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). P/S Ratio (1.962) is also within normal values, averaging (10.493).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.